Evidence map›Paper›PMID 39503579›Full record

ArticleJournal of chemical information and modeling2024

Latin American Natural Product Database (LANaPDB): An Update.

Alejandro Gómez-García, Daniel A Acuña Jiménez, William J Zamora, Haruna L Barazorda-Ccahuana, Miguel Á Chávez-Fumagalli, Marilia Valli, Adriano D Andricopulo, Vanderlan da S Bolzani, Dionisio A Olmedo, Pablo N Solís and 6 more

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Alejandro Gómez-GarcíaDIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de México, Avenida Universidad 3000, Mexico City 04510, Mexico.ORCID 0000-0003-4444-8221
Daniel A Acuña JiménezCBio3 Laboratory, School of Chemistry, University of Costa Rica, San Pedro, San José 11501-2060, Costa Rica.
William J ZamoraCBio3 Laboratory, School of Chemistry, University of Costa Rica, San Pedro, San José 11501-2060, Costa Rica.ORCID 0000-0003-4029-4528
Haruna L Barazorda-CcahuanaComputational Biology and Chemistry Research Group, Vicerrectorado de Investigación, Universidad Católica de Santa María, Arequipa 04000, Peru.
Miguel Á Chávez-FumagalliComputational Biology and Chemistry Research Group, Vicerrectorado de Investigación, Universidad Católica de Santa María, Arequipa 04000, Peru.
Marilia ValliSchool of Pharmaceutical Sciences of Ribeirao Preto (FCFRP), University of São Paulo (USP), Avenida Professor Doutor Zeferino Vaz, s/n, Ribeirao Preto 14040-903, SP, Brazil.
Adriano D AndricopuloLaboratory of Medicinal and Computational Chemistry (LQMC), Centre for Research and Innovation in Biodiversity and Drug Discovery (CIBFar), São Carlos Institute of Physics (IFSC), University of São Paulo (USP), Av. João Dagnone, 1100, São Carlos 13563-120, SP, Brazil.ORCID 0000-0002-0457-818X
Vanderlan da S BolzaniNuclei of Bioassays, Biosynthesis and Ecophysiology of Natural Products (NuBBE), Department of Organic Chemistry, Institute of Chemistry, São Paulo State University (UNESP), Av. Prof. Francisco Degni, 55, Araraquara 14800-900, SP, Brazil.
Dionisio A OlmedoCenter for Pharmacognostic Research on Panamanian Flora (CIFLORPAN), College of Pharmacy, University of Panama, Av. Manuel E. Batista and Jose De Fabrega, Panama City 3366, Panama.
Pablo N SolísCenter for Pharmacognostic Research on Panamanian Flora (CIFLORPAN), College of Pharmacy, University of Panama, Av. Manuel E. Batista and Jose De Fabrega, Panama City 3366, Panama.
Marvin J NúñezNatural Product Research Laboratory, School of Chemistry and Pharmacy, University of El Salvador, Final Ave. Mártires Estudiantes del 30 de Julio, San Salvador 01101, El Salvador.
Johny R Rodríguez PérezGIFAMol Research Group, School of Chemistry Technology, Universidad Tecnológica de Pereira, Pereira 660003, Colombia.ORCID 0000-0002-5216-220X
Hoover A Valencia SánchezGIFAMol Research Group, School of Chemistry Technology, Universidad Tecnológica de Pereira, Pereira 660003, Colombia.
Héctor F Cortés HernándezGIFAMol Research Group, School of Chemistry Technology, Universidad Tecnológica de Pereira, Pereira 660003, Colombia.ORCID 0000-0001-7242-0192
Oscar M Mosquera MartinezGBPN Research Group, School of Chemistry Technology, Universidad Tecnológica de Pereira, Pereira 660003, Colombia.
José L Medina-FrancoDIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de México, Avenida Universidad 3000, Mexico City 04510, Mexico.ORCID 0000-0003-4940-1107

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural product (NP) databases are crucial tools in computer-aided drug design (CADD). Over the past decade, there has been a worldwide effort to assemble information regarding natural products (NPs) isolated and characterized in certain geographical regions. In 2023, it was published LANaPDB, and to our knowledge, this is the first attempt to gather and standardize all the NP databases of Latin America. Herein, we present and analyze in detail the contents of an updated version of LANaPDB, which includes 619 newly added compounds from Colombia, Costa Rica, and Mexico. The present version of LANaPDB has a total of 13 578 compounds, coming from ten databases of seven Latin American countries. A chemoinformatic characterization of LANaPDB was carried out, which includes the structural classification of the compounds, calculation of six physicochemical properties of pharmaceutical interest, and visualization of the chemical space by employing and comparing two different fingerprints (MACCS keys (166-bit) and Morgan2 (2048-bit)). Furthermore, additional analyses were made, and valuable information not included in the first version of LANaPDB was added, which includes structural diversity, molecular complexity, synthetic feasibility, commercial availability, and reported and predicted biological activity. In addition, the LANaPDB compounds were cross-referenced to two of the largest public chemical compound databases annotated with biological activity: ChEMBL and PubChem.

Indexed as

Biological ProductsCheminformaticsDatabases, ChemicalDatabases, PharmaceuticalLatin AmericaBiological Products

Identifiers

PMID39503579
PMCPMC11600509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.